tiprankstipranks
Trending News
More News >
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
:4570
Japanese Market

Immuno-Biological Laboratories Co., Ltd. (4570) Income Statement

Compare
0 Followers

Immuno-Biological Laboratories Co., Ltd. Income Statement

Last quarter (Q3 2024), Immuno-Biological Laboratories Co., Ltd.'s total revenue was ¥236.00M, an increase of 29.04% from the same quarter last year. In Q3, Immuno-Biological Laboratories Co., Ltd.'s net income was ¥62.00M. See Immuno-Biological Laboratories Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 969.53M¥ 816.70M¥ 794.62M¥ 647.58M¥ 602.75M
Gross Profit
¥ 628.34M¥ 517.29M¥ 526.71M¥ 376.70M¥ 346.86M
Operating Expenses
¥ 419.00M¥ 412.99M¥ 468.33M¥ 498.91M¥ 587.83M
Depreciation and Amortization
¥ 15.43M¥ 2.33M¥ -204.93M¥ -143.69M¥ -69.92M
EBITDA
¥ 226.55M¥ 128.11M¥ -332.00M¥ -249.50M¥ -309.88M
Operating Income
¥ 209.35M¥ 104.30M¥ 58.37M¥ -122.22M¥ -240.98M
Other Income/Expenses
¥ 515.00K¥ 20.34M¥ -338.98M¥ -127.92M¥ -69.65M
Pretax Income
¥ 209.86M¥ 124.64M¥ -280.61M¥ -250.14M¥ -310.63M
Net Income
¥ 249.05M¥ 186.69M¥ -289.73M¥ -258.77M¥ -318.83M
Per Share Metrics
Basic EPS
¥ 26.74¥ 20.05¥ -31.11¥ -27.78¥ -34.23
Diluted EPS
¥ 26.74¥ 20.05¥ -31.11¥ -27.78¥ -34.23
Weighted Average Shares Outstanding
9.31M 9.31M 9.31M 9.31M 9.31M
Weighted Average Shares Outstanding (Diluted)
9.31M 9.31M 9.31M 9.31M 9.31M
Currency in JPY

Immuno-Biological Laboratories Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis